2Jones PH,Davidson MH,Stein EA,et al.Comparison of the effi-cacy and safety of rosuvastatin versus atorvastatin,simvastatin,and pravastatin across doses(STELLAR Trial).Am J Cardiol,2003,92(2):152.
4DavidsonM,Ma p,Stein EA,et al.Comparison ofeffectsonlow-density lipoprotein cholesterol and high-density lip-oprotein cholesterolwith rosuvastatin versus atorvastatin inpatients with typeⅡa or hypercholesterlemia[J].Am JCardiol,2002,89(3):268.
5Olsson AG,IstadH,Luurila O,et al.On behalf of the Ro-suvastatin Investihators Group.Effects of rosuvatatin andatorvastatin compared over 52 weeks of treatment in pa-tientswith hypercholesterolemia[J].AmHeart J,2002,144(6):1044.
10Ridker PM,Danielson,Fonseca FA,et al.Justificationfor the use of statins in primary prevention:an interven-tion trial evaluating rosuvastatin[J].N Eng J Med,2008,359(21):2195.
5Michael J, Detkea M D, Yill L, et al. Duloxetine 60rag once daily dosing versus placebo in the acute treatment of major depression[J]. Journal of Psychiatric Research, 2002, 36(6): 383.
6Borgh C, Domai A, Veronesi M, et al. Use of lipid lowering drug and blood pressure control in patients with arterial hypertension[J]. Clin Hypertens, 2002, 4: 1.
7Lament S, Cockcroft J, van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications [J]. Eur Heart J, 2006, 27(21) : 2588.
8Sugawara J, Hayashi K, Yokoi T, et al. Brachial - ankle pulse wave velocity: an index of central arterial stiffness[J]. Hum Hypertens, 2005, 19(5): 401.
9Asmar R, Rudnichi A, Blaeher J, et al. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations [ J ] . Am J Hypertans, 2001, 14 (3) : 91297.
10Vanderlinde N A, Sijbrands E J, Boomsma F, et al. Effect of low - density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin [J]. Hypertention, 2006, 47(6): 1125.
